DTC Ads Lost In Translation, Multicultural Marketers Say At DIA
Executive Summary
Marketers focusing on minority groups told FDA at a Drug Information Association conference in New York Feb. 25 that drug ads should be reviewed by a "culturally competent" advisory group within the agency, and that ads should include an educational component to better target such patient
You may also be interested in...
FDA Advertising Oversight Will Consider Impact Of “Puppies” And The Internet
FDA is pushing forward several research initiatives to help better define how print and broadcast direct-to-consumer ads should be structured, but the agency is adopting a less formal approach to oversight of Internet advertising
Big Pharma Still Hopeful For Next Mega Drugs To Supplement Sales
Drug makers need to continue investing in early-stage research to unveil the next $1 billion-plus drug, panelists at the Argyle conference agree.
Affymax's Share Price Stumbles On Questionable Phase III Hematide Data
Phase III data for Affymax/Takeda's anemia drug for chronic kidney failure signals potential regulatory hurdles in non-dialysis use.